Description
GLP-1/GIP 10mg: Research-Grade Dual GLP-1 and GIP Receptor Peptide for Laboratory Studies
GLP-1/GIP 10mg is a high-purity, research-grade peptide designed for laboratory investigations involving GLP-1 (glucagon-like peptide-1) and GIP (gastric inhibitory polypeptide) receptor pathways, peptide–receptor interactions, and metabolic signaling studies.
This peptide is intended exclusively for controlled scientific research. It is not approved for human consumption, clinical use, or therapeutic application.
What is GLP-1/GIP?
GLP-1/GIP is a synthetic dual-action peptide that activates GLP-1 and GIP receptors. It is widely used in laboratory settings to study:
GLP-1 and GIP receptor signaling
Peptide–receptor interaction assays
Cellular receptor activation studies
Metabolic pathway modeling in vitro and ex vivo
Endocrine system research and metabolic science applications
The 10mg vial provides researchers with sufficient peptide for single-dose or multi-dose experimental protocols, short-term trials, and in-depth laboratory investigations.
Key Research Applications of GLP-1/GIP 10mg
• GLP-1 & GIP Receptor Signaling Studies – Controlled experiments on receptor binding and intracellular signaling mechanisms.
• Peptide–Receptor Interaction Research – Studying dual receptor pathway interactions in vitro or ex vivo.
• Metabolic Pathway Investigation – Laboratory modeling of peptide-mediated signaling in metabolic research.
• Endocrine & Cellular Research – Controlled assays on receptor activation, intracellular pathways, and signaling dynamics.
• Experimental Protocols & Dose-Response Studies – Multi-dose or single-dose laboratory investigations.
Why Choose GLP-1/GIP 10mg for Research?
GLP-1/GIP 10mg is manufactured under strict research-grade standards, ensuring high purity, reproducibility, and batch-to-batch consistency for laboratory applications.
High-Purity Manufacturing – Produced using validated peptide synthesis protocols.
Consistent Quality Control – Each batch is tested for identity, purity, and stability.
Optimal Quantity for Research – Suitable for short-term, dose-response, or multi-phase laboratory studies.
Research-Only Designation – Intended exclusively for laboratory use in controlled research environments.
Quality Assurance & Purity Guarantee
ExoLabz provides a purity testing guarantee for all research peptides. Researchers may independently verify the purity of GLP-1/GIP 10mg. If results indicate deviation from stated standards, a full refund and reimbursement of testing costs will be provided, ensuring reliable research material.
Important Legal Disclaimer
For Research Purposes Only
GLP-1/GIP 10mg is strictly intended for laboratory research and scientific investigation. It is not for human consumption, veterinary use, or clinical application.
This peptide has not been approved by the FDA, Health Canada, or other regulatory authorities for medical or therapeutic use.
By purchasing, you confirm that GLP-1/GIP 10mg will be used solely for lawful research purposes by qualified professionals in controlled laboratory settings.
Research Literature
Peer-reviewed studies involving this compound and its class. All findings listed are from in vitro, cell culture or animal models and are provided for scientific reference only. This product is supplied for laboratory research and is not approved for human consumption, clinical, or veterinary use.
- Willard FS, et al. JCI Insight. 2020;5(17):e140532. In HEK293 and CHO-K1 cells, measured competition radioligand binding, cAMP accumulation, beta-arrestin recruitment and receptor internalisation at human GIPR and GLP-1R. Source · PMID 32730231
- Zhao F, et al. Nat Commun. 2022;13:1057. Solved five cryo-EM structures of Gs-coupled GIPR, GLP-1R and GCGR at 3.0-3.5 A and measured cAMP potency across site-directed receptor mutants. Source · PMID 35217653
- Knerr PJ, et al. Mol Metab. 2022;63:101533. In diet-induced obese mice, measured food intake, body weight, glucose control and energy expenditure across triagonists with tuned receptor potency ratios. Source · PMID 35809773
Literature notes: References concern receptor pharmacology and preclinical models. Clinical literature is outside the scope of this list.
Related Research Compounds
Browse more compounds in Incretin & Metabolic Peptides, or view the full research peptide catalogue.
